TOP 20

Top 20 Monoclonal Antibodies of 2026

Shots: Keytruda, Dupixent, and Skyrizi emerged as the leading monoclonal antibody products in 2025, generating revenues of $31.68B, $18.48B, and $17.56B, respectively. Strong demand across approved indications, broader patient adoption, market share gains, and expansion into new treatment areas supported growth among the leading products The global monoclonal antibodies market was valued at $267.6B in…

3 hours ago

Top 20 Generic Pharma Companies of 2026

Shots: Sandoz, Sun Pharma, and Shanghai Fosun Pharma emerged as the leading generic pharmaceutical companies in 2026, with 2025 revenues of $11.08B, $6.55B, and $5.92B, respectively. Strong demand for biosimilars, continued portfolio expansion, new product launches, and broader access to affordable medicines supported growth across the leading companies The global generics landscape continues to evolve…

August 14, 2026

Top 20 R&D Spending Biopharma Companies of 2026

Shots: Merck & Co., Roche, and Johnson & Johnson emerged as the leading pharmaceutical companies by R&D expenditure in 2025, investing $15.78B, $15.49B, and $14.66B, respectively. Continued investments in late-stage clinical programs, pipeline expansion, advanced technologies, and strategic business development reinforced their commitment to driving pharmaceutical innovation Global biopharmaceutical R&D investment continues to accelerate as…

July 31, 2026

Top 20 Immunology Companies of 2026

Shots: AbbVie led the global immunology market with $30.4B in immunology revenue in 2025, followed by Sanofi ($19.08B) and Johnson & Johnson ($15.72B). Continued demand for biologics and targeted therapies across autoimmune and inflammatory diseases supported strong commercial performance among leading companies. The global immunology market, valued at $108.4B in 2024, is projected to…

July 17, 2026

Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2006-2025)

Shots: PharmaShots' latest report chronicles the transformation of the global biopharma industry from 2006–2025, highlighting how innovation, strategic M&A, AI adoption, and evolving commercialization strategies have reshaped the competitive landscape while companies navigated patent cliffs, pricing pressures, and shifting market dynamics. The report tracks the rise and fall of leading biopharma companies over two decades driven by…

July 10, 2026

Top 20 Vaccines of 2026

Shots: The global vaccine market, valued at $72.8B in 2025 and projected to reach $115.8B by 2033, continues to benefit from expanding immunization coverage, growing awareness of infectious disease prevention, and innovation across RSV, pneumococcal, HPV, and mRNA vaccines. Pfizer’s Prevnar Family led the market with $6.49B in revenue, followed by Merck’s Gardasil/Gardasil 9 ($5.23B)…

June 26, 2026

Top 20 Nutraceutical Companies of 2026

Shots: The global nutraceutical market is advancing through preventive healthcare, personalized nutrition, probiotics, sports nutrition, and healthy ageing solutions. In 2025, Nestlé led the industry with $18.1B in nutraceutical revenue, followed by Danone ($10.91B) and Abbott Nutrition ($8.45B), reflecting strong demand for science-backed wellness products Valued at $636.2B in 2025, the global nutraceutical market is…

June 12, 2026

Top 20 Diagnostics Companies of 2026

Shots: The global diagnostics market is rapidly evolving through AI-powered imaging, molecular testing, precision medicine, and digital pathology solutions. In 2025, Siemens Healthineers led the industry with $20.54B in diagnostics revenue, followed by Roche at $17.52B and GE HealthCare at $17.49B, reflecting the growing adoption of advanced imaging, lab automation, and AI-driven diagnostics across global…

May 29, 2026

Top 20 Medical Device Companies of 2026

Top 20 Medical Device Companies of 2026 Shots: The global medical devices market is entering a new era of transformation, powered by AI-driven diagnostics, robotic surgery, cardiovascular breakthroughs, and minimally invasive innovation. Valued at $572.31B in 2025, the market is racing toward the $1T milestone by 2034. In FY2025, Medtronic dominated with $35.48B in revenue,…

May 15, 2026

PharmaShots Awards 2026: Celebrating the Titans Transforming the Future of Global Healthcare

Shots: PharmaShots Awards 2026 celebrates the industry’s most influential innovators across biopharma, MedTech, diagnostics, generics, nutraceuticals, animal health, digital health, and AI-driven drug discovery spotlighting organizations redefining the future of global healthcare. From Eli Lilly, Pfizer, and AbbVie to Medtronic, Roche, Siemens Healthineers, and XtalPi, this year’s awardees exemplify scientific excellence, breakthrough innovation, and a relentless commitment to…

May 2, 2026